What antibiotics are effective against Group B strep (Streptococcus agalactiae) infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotics Effective Against Group B Streptococcus (GBS)

Penicillin G remains the first-line antibiotic for Group B Streptococcus infections due to its high efficacy and safety profile. 1, 2

First-Line Antibiotics for GBS

  • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery/resolution 1
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours 1
  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours (for patients with non-anaphylactic penicillin allergy) 1

Alternative Antibiotics for Penicillin-Allergic Patients

For patients with severe penicillin allergy (history of anaphylaxis, angioedema, respiratory distress, or urticaria):

  • Clindamycin: 600 mg IV every 8 hours (only if GBS isolate is confirmed susceptible to both clindamycin and erythromycin, and negative for inducible clindamycin resistance) 3, 1
  • Vancomycin: 15-20 mg/kg IV every 12 hours (if GBS susceptibility to clindamycin is unknown or shows resistance) 3, 1, 4

Antimicrobial Susceptibility Considerations

  • All GBS isolates are generally susceptible to penicillin, ampicillin, and vancomycin 2, 4, 5
  • Resistance to macrolides (erythromycin, azithromycin) and clindamycin is increasing, with studies showing resistance rates of up to 31% for azithromycin and 19% for clindamycin 5
  • For penicillin-allergic patients, antimicrobial susceptibility testing should be performed on GBS isolates to guide therapy 3, 1

Treatment Duration

  • For uncomplicated GBS infections: 7-10 days of therapy 1
  • For complicated infections (slow clinical response, undrainable foci, immunodeficiency): 14 days or longer 1
  • For GBS bacteremia: continue treatment until blood cultures are negative and clinical improvement is observed 1

Special Considerations

  • Penicillin G achieves adequate drug levels in fetal circulation and amniotic fluid while avoiding neurotoxicity 3
  • For urinary tract infections with GBS, nitrofurantoin may be effective as studies show minimal resistance 5
  • In pregnant women at risk for rapid delivery, intramuscular benzathine penicillin G (Bicillin L-A) may be used as adjunctive therapy, though it's insufficient as sole therapy 6

Monitoring and Follow-up

  • For GBS bacteremia, obtain follow-up blood cultures to document clearance 1
  • Consider oral step-down therapy after clinical improvement, bacteremia clearance, and exclusion of endocarditis or metastatic abscess 1

Key Pitfalls to Avoid

  1. Failing to perform susceptibility testing in penicillin-allergic patients, which can lead to treatment failure
  2. Using erythromycin for GBS prophylaxis, which is no longer recommended due to increasing resistance 3, 5
  3. Inadequate dosing intervals - penicillin G should be administered every 4 hours to maintain effective concentrations 7
  4. Not considering the severity of penicillin allergy when selecting alternative antibiotics
  5. Treating asymptomatic GBS colonization outside of specific situations like pregnancy 1

By following these evidence-based recommendations, clinicians can effectively treat Group B Streptococcus infections while minimizing the risk of treatment failure and antibiotic resistance.

References

Guideline

Prevention and Treatment of Group B Streptococcal Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Research

Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.